Fraser Claire
- SEC CIK
- 0001382031
No open-market purchases or sales filed in the past year.
Current role at each company
- MCRB Seres Therapeutics, Inc.Directoras of Jul 10, 2026
- WAT Waters CorpDirectoras of Feb 27, 2026
- BDX Becton Dickinson & CoDirectoras of Sep 11, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Fraser Claire as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BDX Becton Dickinson & Co
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 (view filing) | Sep 10 | 1 day | Fraser ClaireDirector | SSale | −917 | $187.50 | −$171.9K | −4.0%22.2K after | |
| Aug 8, 2025 (view filing) | Aug 8 | Same day | Fraser ClaireDirector | SSale | −863 | $192.30 | −$166.0K | −3.6%23.1K after | |
| Aug 30, 2023 (view filing) | Aug 28 | 2 days | Fraser ClaireDirector | SSale | −848 | $281.66 | −$238.8K | −3.8%21.6K after | |
| Feb 10, 2022 (view filing) | Feb 8 | 2 days | Fraser ClaireDirector | SSale | −841 | $271.70 | −$228.5K | −3.8%21.6K after | |
| Aug 18, 2021 (view filing) | Aug 18 | Same day | Fraser ClaireDirector | SSale | −387 | $251.58 | −$97.4K | −1.9%20.2K after |